Suppr超能文献

肠系膜脂膜炎:患病率、临床放射学表现及5年随访

Mesenteric panniculitis: prevalence, clinicoradiological presentation and 5-year follow-up.

作者信息

van Putte-Katier N, van Bommel E F H, Elgersma O E, Hendriksz T R

机构信息

1 Department of Radiology, Albert Schweitzer Ziekenhuis, Netherlands.

出版信息

Br J Radiol. 2014 Dec;87(1044):20140451. doi: 10.1259/bjr.20140451. Epub 2014 Oct 1.

Abstract

OBJECTIVE

To determine prevalence, clinicoradiological characteristics and outcome of patients with mesenteric panniculitis (MP) in a large hospital-based population.

METHODS

Consecutive abdominal CT examinations of 3820 patients were evaluated for MP. Clinical characteristics, therapy and outcome of patients with MP were evaluated during a 5-year follow-up period. A matched pair analysis was performed to further investigate the relation between MP and malignancy.

RESULTS

94 (2.5%) patients with MP were identified (mean age, 66.6 ± 11.2 years, 70.2% male). MP coexisted with malignancy (especially prostatic carcinoma) in 48.9% of patients, and this was slightly but significantly higher than in age- and sex-matched control patients (n = 188, 46.3%). In 48 patients, MP was presumed to be idiopathic. The most frequent presenting symptom was pain (54.3%). Laboratory findings revealed increased acute-phase reactants in half of the patients with MP. CT findings included increased density of mesenterial fat (mean, -56.8 ± 10.8 HU), fat ring sign, tumoural pseudocapsule and small soft-tissue nodules. Patients with MP (14.6%) developed significantly more malignancies during a 5-year follow-up than did the control group (6.9%). One patient was treated with prednisone without satisfactory response.

CONCLUSION

The prevalence of MP in this study was 2.5%. In most patients, radiologic features included increased mesenteric fat density, fat ring sign and small soft-tissue nodules. MP was associated with a significant higher prevalence of coexisting malignancies and a higher prevalence of future cancer development.

ADVANCES IN KNOWLEDGE

A more accurate prevalence of MP on CT is demonstrated. An underlying malignancy may play a role.

摘要

目的

确定一家大型医院人群中肠系膜脂膜炎(MP)患者的患病率、临床放射学特征及预后。

方法

对3820例患者的连续腹部CT检查进行MP评估。在5年随访期内评估MP患者的临床特征、治疗及预后。进行配对分析以进一步研究MP与恶性肿瘤之间的关系。

结果

共识别出94例(2.5%)MP患者(平均年龄66.6±11.2岁,70.2%为男性)。48.9%的患者MP与恶性肿瘤(尤其是前列腺癌)共存,这略高于年龄和性别匹配的对照患者(n = 188,46.3%),且差异有统计学意义。48例患者的MP被认为是特发性的。最常见的症状是疼痛(54.3%)。实验室检查发现,一半的MP患者急性期反应物升高。CT表现包括肠系膜脂肪密度增加(平均-56.8±10.8 HU)、脂肪环征、肿瘤假包膜和小软组织结节。MP患者在5年随访期间发生恶性肿瘤的比例(14.6%)明显高于对照组(6.9%)。1例患者接受泼尼松治疗但效果不佳。

结论

本研究中MP的患病率为2.5%。大多数患者的放射学特征包括肠系膜脂肪密度增加、脂肪环征和小软组织结节。MP与共存恶性肿瘤的患病率显著较高以及未来癌症发生的患病率较高相关。

知识进展

显示了CT上MP更准确的患病率。潜在的恶性肿瘤可能起作用。

相似文献

1
Mesenteric panniculitis: prevalence, clinicoradiological presentation and 5-year follow-up.
Br J Radiol. 2014 Dec;87(1044):20140451. doi: 10.1259/bjr.20140451. Epub 2014 Oct 1.
2
Mesenteric panniculitis. Part 2: prevalence and natural course: MDCT prospective study.
JBR-BTR. 2011 Sep-Oct;94(5):241-6. doi: 10.5334/jbr-btr.659.
3
Mesenteric Panniculitis (MP) in CT - A Predictor of Malignancy?
Rofo. 2016 Oct;188(10):926-32. doi: 10.1055/s-0042-110100. Epub 2016 Aug 16.
4
Is mesenteric panniculitis truely a paraneoplastic phenomenon? A matched pair analysis.
Eur J Radiol. 2013 Nov;82(11):1853-9. doi: 10.1016/j.ejrad.2013.06.023. Epub 2013 Jul 29.
5
Mesenteric panniculitis: review of consecutive abdominal MDCT examinations with a matched-pair analysis.
Acta Radiol. 2016 Dec;57(12):1438-1444. doi: 10.1177/0284185116629829. Epub 2016 Jul 19.
6
Mesenteric panniculitis: systematic review of cross-sectional imaging findings and risk of subsequent malignancy.
Eur Radiol. 2016 Dec;26(12):4531-4537. doi: 10.1007/s00330-016-4298-2. Epub 2016 Apr 5.
8
CT evaluation of mesenteric panniculitis: prevalence and associated diseases.
AJR Am J Roentgenol. 2000 Feb;174(2):427-31. doi: 10.2214/ajr.174.2.1740427.
9
Mesenteric Panniculitis (MP): A Frequent Coincidental CT Finding of Debatable Clinical Significance.
Rofo. 2018 Nov;190(11):1044-1052. doi: 10.1055/a-0633-3558. Epub 2018 Sep 6.
10
CT features associated with underlying malignancy in patients with diagnosed mesenteric panniculitis.
Diagn Interv Imaging. 2022 Sep;103(9):394-400. doi: 10.1016/j.diii.2022.06.009. Epub 2022 Jul 15.

引用本文的文献

2
Mesenteric Panniculitis in a Renal Transplant Patient With Systemic Lupus Erythematosus.
Cureus. 2025 Mar 10;17(3):e80340. doi: 10.7759/cureus.80340. eCollection 2025 Mar.
3
Mesenteric panniculitis: A case report.
Int J Surg Case Rep. 2025 Feb;127:111000. doi: 10.1016/j.ijscr.2025.111000. Epub 2025 Feb 1.
4
Mesenteric Panniculitis.
Inflamm Intest Dis. 2024 May 22;9(1):157-164. doi: 10.1159/000539432. eCollection 2024 Jan-Dec.
5
A review of 17 cases of mesenteric panniculitis in Zhengzhou Ninth People's Hospital in China.
BMC Gastroenterol. 2024 Jan 24;24(1):48. doi: 10.1186/s12876-024-03136-8.
6
Sclerosing mesenteritis: a rare disease involving the adipose tissue of the bowel mesentery.
Intern Emerg Med. 2024 Aug;19(5):1493-1495. doi: 10.1007/s11739-023-03510-6. Epub 2024 Jan 9.
7
A Clinical Review of Mesenteric Panniculitis.
Gastroenterol Hepatol (N Y). 2023 Apr;19(4):211-218.
8
Sclerosing mesenteritis following immune checkpoint inhibitor therapy.
J Cancer Res Clin Oncol. 2023 Sep;149(11):9221-9227. doi: 10.1007/s00432-023-04802-2. Epub 2023 May 17.
9
Conservative Management of Mesenteric Panniculitis in a Remote Island.
Case Rep Surg. 2023 Apr 21;2023:3335738. doi: 10.1155/2023/3335738. eCollection 2023.

本文引用的文献

1
Is mesenteric panniculitis truely a paraneoplastic phenomenon? A matched pair analysis.
Eur J Radiol. 2013 Nov;82(11):1853-9. doi: 10.1016/j.ejrad.2013.06.023. Epub 2013 Jul 29.
3
Mesenteric panniculitis: a paraneoplastic phenomenon?
Dis Colon Rectum. 2012 Jul;55(7):806-9. doi: 10.1097/DCR.0b013e318252e286.
4
Mesenteric panniculitis. Part 2: prevalence and natural course: MDCT prospective study.
JBR-BTR. 2011 Sep-Oct;94(5):241-6. doi: 10.5334/jbr-btr.659.
5
Mesenteric panniculitis. Part 1: MDCT--pictorial review.
JBR-BTR. 2011 Sep-Oct;94(5):229-40. doi: 10.5334/jbr-btr.658.
6
Chylous ascites in a patient with mesenteric panniculits.
J Clin Gastroenterol. 2008 Mar;42(3):327-8. doi: 10.1097/MCG.0b013e31802c346d.
7
Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients.
Clin Gastroenterol Hepatol. 2007 May;5(5):589-96; quiz 523-4. doi: 10.1016/j.cgh.2007.02.032.
8
Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in intestinal and mesenteric diseases.
Nat Clin Pract Gastroenterol Hepatol. 2005 Feb;2(2):103-11. doi: 10.1038/ncpgasthep0090.
9
Mesenteric panniculitis: US and CT features.
Eur Radiol. 2004 Dec;14(12):2242-8. doi: 10.1007/s00330-004-2429-7. Epub 2004 Aug 5.
10
A fatal case of sclerosing mesenteritis.
Dig Liver Dis. 2004 Feb;36(2):153-6. doi: 10.1016/j.dld.2003.07.009.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验